Patent details

Basic Information

Publication number:

EP3246017

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171603129

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABLE LIQUID FORMULATION OF AMG 416 HCL (ETELCALCETIDE)

French Title of Invention:

FORMULATION LIQUIDE STABLE D'AMG 416 HCL (ETELCALCETIDE)

German Title of Invention:

STABILE, FLÜSSIGE FORMULIERUNG VON AMG 416 HCL (ETELCALCETIDE)

SPC Number:

Dates

Filing date:

27/06/2014

Grant date:

24/03/2021

EP Publication Date:

22/11/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/03/2021

EP B1 Publication Date:

24/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/06/2021

Expiration date:

27/06/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/03/2021

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive Thousand Oaks, California 91320, United States (US)

Inventor

1

Name:

YIN, Qun

Address:

United States (US)

2

Name:

MACLEAN, Derek

Address:

United States (US)

Priority

Priority Number:

201361840618 P

Priority Date:

28/06/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/08; A61P 3/14; A61P 5/00; A61K 38/08;

Publication

European Patent Bulletin

1

Issue number:

202112

Publication date:

24/03/2021

Description:

Grant (B1)

2

Issue number:

202204

Publication date:

26/01/2022

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages